RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      Use of Cellulose and Recent Research into Butyrate

      한글로보기

      https://www.riss.kr/link?id=A99530265

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      국문 초록 (Abstract)

      지구상에는 약 5,400여 종의 포유동물이 있고 그 중 약 1,000여 종은 풀을 뜯어 먹고 사는 초식동물이다. 초식 동물 중에서 약 250여 종이 반추동물로 알려져 있다. 반추동물인 소와 양은 반추위에서 주로 발효가 일어나지만 비반추동물인 돼지와 사람은 맹장과 결장, 직장에서 주로 발효가 일어난다. 반추위 미생물의 종류와 우점도 Bacteroidetes 51%, Firmicutes 43% 존재하며, 사람의 대장미생물의 우점도Firmicutes 65%, Bacteroidetes 25%로 존재 한다. 풀의 세포벽 구성성분은 미생물에 의해 분해, 발효에 의해 SCFA (short chain fatty acid)를 생성하게 되고 acetate, propionate, butyrate 생성비율은 60:25:15이다. 장내 primary butyrate transporter인 MCT1 (monocarboxylatetransports-1)에 의해서 흡수된 butyrate는 SCFA receptor GPR43과 GPR41을 활성화시킨다. Butyrate는 강력한 anti-tumorigenic 기능을 가지고 있다. Butyrate는 다양한 cancer cell에 효과를 나타내며 세포 내의 기능 조절에 기여하고, 암세포사멸을 유도하는 특성이 있다. Butyrate는 caspase의 활성화, HDAC (histone deacetylase) 활성을 억제하여apoptosis를 유도하고, p53 발현증가로 cell cycle arrest와 apoptosis를 유도한다. SCFA의 항 염증작용으로는 장 상피세포에서 IL-8 발현 감소, NO합성과 NF-kB (nuclear factor kB)의 활성을 억제하여 염증으로 인한 암 발생을 억제한다. Butyrate는 장 점막의 생리적 기능을 유지하는데 중요한 역할을 하며 IBD (inflammatory bowel disease) 치료법으로 이용되고 있다.
      번역하기

      지구상에는 약 5,400여 종의 포유동물이 있고 그 중 약 1,000여 종은 풀을 뜯어 먹고 사는 초식동물이다. 초식 동물 중에서 약 250여 종이 반추동물로 알려져 있다. 반추동물인 소와 양은 반추위...

      지구상에는 약 5,400여 종의 포유동물이 있고 그 중 약 1,000여 종은 풀을 뜯어 먹고 사는 초식동물이다. 초식 동물 중에서 약 250여 종이 반추동물로 알려져 있다. 반추동물인 소와 양은 반추위에서 주로 발효가 일어나지만 비반추동물인 돼지와 사람은 맹장과 결장, 직장에서 주로 발효가 일어난다. 반추위 미생물의 종류와 우점도 Bacteroidetes 51%, Firmicutes 43% 존재하며, 사람의 대장미생물의 우점도Firmicutes 65%, Bacteroidetes 25%로 존재 한다. 풀의 세포벽 구성성분은 미생물에 의해 분해, 발효에 의해 SCFA (short chain fatty acid)를 생성하게 되고 acetate, propionate, butyrate 생성비율은 60:25:15이다. 장내 primary butyrate transporter인 MCT1 (monocarboxylatetransports-1)에 의해서 흡수된 butyrate는 SCFA receptor GPR43과 GPR41을 활성화시킨다. Butyrate는 강력한 anti-tumorigenic 기능을 가지고 있다. Butyrate는 다양한 cancer cell에 효과를 나타내며 세포 내의 기능 조절에 기여하고, 암세포사멸을 유도하는 특성이 있다. Butyrate는 caspase의 활성화, HDAC (histone deacetylase) 활성을 억제하여apoptosis를 유도하고, p53 발현증가로 cell cycle arrest와 apoptosis를 유도한다. SCFA의 항 염증작용으로는 장 상피세포에서 IL-8 발현 감소, NO합성과 NF-kB (nuclear factor kB)의 활성을 억제하여 염증으로 인한 암 발생을 억제한다. Butyrate는 장 점막의 생리적 기능을 유지하는데 중요한 역할을 하며 IBD (inflammatory bowel disease) 치료법으로 이용되고 있다.

      더보기

      다국어 초록 (Multilingual Abstract)

      On earth, there are about 5,400 kinds of mammals, of which about 1,000 kinds are herbivores. Among herbivores, about 250 kinds are known to be ruminants. As for cattle and sheep, which are ruminants, fermentation takes places mainly in their rumen; in contrast, for pigs and men, which are non-ruminants, fermentation takes place mainly in their caecum, colon, and rectum. As for the kind and dominance of rumen microorganisms, Bacteroidetes account for 51% and Firmicutes for 43%. As for the dominance of the large intestine microorganisms in men, Firmicutes account for 65% and Bacteroidetes for 25%. Cell wall components are decomposed by microorganisms, and short chain fatty acids (SCFAs) are generated through fermentation; the ratio of acetate, propionate, and butyrate generate is 60:25:15. Butyrate absorbed through the primary butyrate transporter MCT1 (mono carboxylate transports-1) in the intestines activates such SCFA receptors as GPR43 and GPR41. Butyrate has a strong anti-tumorigenic function. Butyrate is characterized by the fact that it has an effect on many cancer cells, contributes to the coordination of functions in the cells, and induces cancer apoptosis. Butyrate activates caspase but inhibits the activity of HDAC (histone deacetylase), so as to induce apoptosis. In addition, it increases p53 expression, so as to induce cell cycle arrest and apoptosis. Anti-inflammation actions of SCFA include the reduction of IL-8 expression in intestinal epithelial cells, the inhibition of NO synthesis, and the restraint of the activity of NF-kB (nuclear factor kB), so as to suppress the occurrence of cancers caused by inflammation. Butyrate plays an important role in maintaining physiological functions of intestinal mucous membranes and is used as a cure for inflammatory bowel disease (IBD).
      번역하기

      On earth, there are about 5,400 kinds of mammals, of which about 1,000 kinds are herbivores. Among herbivores, about 250 kinds are known to be ruminants. As for cattle and sheep, which are ruminants, fermentation takes places mainly in their rumen; in...

      On earth, there are about 5,400 kinds of mammals, of which about 1,000 kinds are herbivores. Among herbivores, about 250 kinds are known to be ruminants. As for cattle and sheep, which are ruminants, fermentation takes places mainly in their rumen; in contrast, for pigs and men, which are non-ruminants, fermentation takes place mainly in their caecum, colon, and rectum. As for the kind and dominance of rumen microorganisms, Bacteroidetes account for 51% and Firmicutes for 43%. As for the dominance of the large intestine microorganisms in men, Firmicutes account for 65% and Bacteroidetes for 25%. Cell wall components are decomposed by microorganisms, and short chain fatty acids (SCFAs) are generated through fermentation; the ratio of acetate, propionate, and butyrate generate is 60:25:15. Butyrate absorbed through the primary butyrate transporter MCT1 (mono carboxylate transports-1) in the intestines activates such SCFA receptors as GPR43 and GPR41. Butyrate has a strong anti-tumorigenic function. Butyrate is characterized by the fact that it has an effect on many cancer cells, contributes to the coordination of functions in the cells, and induces cancer apoptosis. Butyrate activates caspase but inhibits the activity of HDAC (histone deacetylase), so as to induce apoptosis. In addition, it increases p53 expression, so as to induce cell cycle arrest and apoptosis. Anti-inflammation actions of SCFA include the reduction of IL-8 expression in intestinal epithelial cells, the inhibition of NO synthesis, and the restraint of the activity of NF-kB (nuclear factor kB), so as to suppress the occurrence of cancers caused by inflammation. Butyrate plays an important role in maintaining physiological functions of intestinal mucous membranes and is used as a cure for inflammatory bowel disease (IBD).

      더보기

      목차 (Table of Contents)

      • abstract
      • Digestive organ of ruminant and mono-gastric animals
      • Ruminant microorganisms
      • Microorganisms in the intestines of men
      • Microorganisms that decompose polysaccharide
      • abstract
      • Digestive organ of ruminant and mono-gastric animals
      • Ruminant microorganisms
      • Microorganisms in the intestines of men
      • Microorganisms that decompose polysaccharide
      • SCFAs
      • Anti-tumorigenic properties of butyrate
      • Regulation of Inflammation by butyrate
      • Conclusions
      • References
      • 초록
      더보기

      참고문헌 (Reference)

      1 Rincon, M. T., "Unconventional mode of attachment of the Ruminococcus flavefaciens cellulosome to the cell surface" 187 : 7569-7578, 2005

      2 Iacomino, G., "Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate" 285 : 1280-1289, 2001

      3 Kim, E. J., "Trans-10, cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth" 283 : 357-367, 2002

      4 Brown, A. J., "The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids" 278 : 11312-11319, 2003

      5 Pryde, S. E., "The microbiology of butyrate formation in the human colon" 217 : 133-139, 2002

      6 Hu, S., "The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer" 6 : 16221-, 2011

      7 Hyzd'alova, M., "The interaction of butyrate with TNF-Alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kB activation" 44 : 33-43, 2008

      8 Turnbaugh, P. J., "The human microbiome project" 449 : 804-810, 2007

      9 Dave, M., "The human gut microbiome: current knowledge, challenges, and future directions" 4 : 246-257, 2012

      10 Berni Canani, R., "The epigenetic effects of butyrate: potential therapeutic implications for clinical practice" 4 : 4-, 2012

      1 Rincon, M. T., "Unconventional mode of attachment of the Ruminococcus flavefaciens cellulosome to the cell surface" 187 : 7569-7578, 2005

      2 Iacomino, G., "Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate" 285 : 1280-1289, 2001

      3 Kim, E. J., "Trans-10, cis-12-conjugated linoleic acid inhibits Caco-2 colon cancer cell growth" 283 : 357-367, 2002

      4 Brown, A. J., "The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids" 278 : 11312-11319, 2003

      5 Pryde, S. E., "The microbiology of butyrate formation in the human colon" 217 : 133-139, 2002

      6 Hu, S., "The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer" 6 : 16221-, 2011

      7 Hyzd'alova, M., "The interaction of butyrate with TNF-Alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kB activation" 44 : 33-43, 2008

      8 Turnbaugh, P. J., "The human microbiome project" 449 : 804-810, 2007

      9 Dave, M., "The human gut microbiome: current knowledge, challenges, and future directions" 4 : 246-257, 2012

      10 Berni Canani, R., "The epigenetic effects of butyrate: potential therapeutic implications for clinical practice" 4 : 4-, 2012

      11 Hinnebusch, B. F., "The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation" 132 : 1012-1017, 2002

      12 Duchmann, R., "T cell specificity and cross reactivity towards Enterobacteria, Bacteroides, Bifidobacterium, and antigens from resident intestinal flora in humans" 44 : 812-818, 1999

      13 Pajak, B., "Sodium butyrate sensitizes human colon adenocarcinoma Colo 205 cells to both intrinsic and TNF-Alpha-dependent extrinsic apoptosis" 14 : 203-217, 2009

      14 Natoni, F., "Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathways" 1745 : 318-329, 2005

      15 Topping, D. L., "Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides" 81 : 1031-1064, 2001

      16 Karaki, S., "Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine" 324 : 353-360, 2006

      17 Vinolo, M. A., "SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor" 6 : 21205-, 2011

      18 Tajima, K., "Rumen bacterial diversity as determined by sequence analysis of 16S rDNA libraries" 29 : 159-169, 1999

      19 Tazoe, H., "Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions" 59 (59): 251-262, 2008

      20 Hamer, H. M., "Review article: the role of butyrate on colonic function" 27 : 104-119, 2008

      21 Maslowski, K. M., "Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43" 461 : 1282-1286, 2009

      22 Vinolo, M. A., "Regulation of inflammation by short chain fatty acids" 3 : 858-876, 2011

      23 Wachtershauser, A., "Rationale for the luminal provision of butyrate in intestinal diseases" 39 : 164-171, 2000

      24 Tan, H. T., "Quantitative and temporal proteome analysis of butyrate-treated colorectal cancer cells" 7 : 1174-1185, 2008

      25 Fung, K. Y., "Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells" 8 : 1220-1227, 2009

      26 Tan, S., "Proteome analysis of butyrate-treated human colon cancer cells (HT-29)" 98 : 523-531, 2002

      27 Flint, H. J., "Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis" 6 : 121-131, 2008

      28 Von Soest, P. J., "Nutritional ecology of the ruminant" Q & B Books Inc 1982

      29 Diaz Heijtz, R., "Normal gut microbiota modulates brain development and behavior" 108 : 3047-3052, 2011

      30 Cho, K. K., "Molecular cloning and expression of a novel family a endoglucanase gene from Fibrobacter succinogenes S85 in Escherichia coli" 27 : 475-481, 2000

      31 Uronis, J. M., "Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility" 4 : 6026-, 2009

      32 Ley, R. E., "Microbial ecology: human gut microbes associated with obesity" 444 : 1022-1023, 2006

      33 Daly, K., "Microarray analysis of butyrate regulated genes in colonic epithelial cells" 25 : 49-62, 2006

      34 Vijay-Kumar, M., "Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5" 328 : 228-231, 2010

      35 Wilson, D. E., "Mammal Species of the world. 3rd eds" Johns Hopkins Univ Pr 2005

      36 Church, D. C., "Livestock feeds and feedings" Q & B Books Inc 1984

      37 Lazarova, D. L., "Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate" 110 : 523-531, 2004

      38 Sacks Sacks, F. M., "Lack of an effect of dietary saturated fat and cholesterol on blood pressure in normotensives" 6 : 193-198, 1984

      39 Flint, H. J., "Interactions and competition within the microbial commmono-gastricy of the human colon: links between diet and health" 9 : 1101-1111, 2007

      40 Huang, N., "Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation" 9 : 27-36, 1997

      41 Walker, A. W., "Influence of substrate and environmental factors on human gut microbial ecology and metabolism" University of Dundee 2006

      42 Hallert, C., "Increasing fecal butyrate in ulcerative colitis patients by diet: controlled pilot study" 9 : 116-121, 2003

      43 Olmo, N., "In vitro models for the study of the effect of butyrate on human colon adenocarcinoma cells" 21 : 262-270, 2007

      44 Roy, M. J., "In Vitro studies on the inhibition of colon cancer by butyrate and carnitine" 25 : 1193-1201, 2009

      45 De Filippo, C., "Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa" 107 : 14691-14696, 2010

      46 Nilsson, N. E., "Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids" 303 : 1047-1052, 2003

      47 Hofmanova, J., "Human fetal colon cells and colon cancer cells respond differently to butyrate and PUFAs" 53 (53): 102-113, 2009

      48 Hooper, L. V., "How host-microbial interactions shape the nutrient environment of the mammalian intestine" 22 : 283-307, 2002

      49 Backhed, F., "Host-bacterial mutualism in the human intestine" 307 : 1915-1920, 2005

      50 김현정, "Histone deacetylase inhibitors: Molecular mechanisms of action and clinical trials as anti-cancer drugs" e-Century Publishing Corporation 3 (3): 166-179, 2011

      51 Wagner, J. M., "Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy" 1 : 117-136, 2010

      52 DiBaise, J. K., "Gut microbiota and its possible relationship with obesity" 83 : 460-469, 2008

      53 Tang, Y., "G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer" 128 : 847-856, 2011

      54 Sina, C., "G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation" 183 : 7514-7522, 2009

      55 Le Poul, E., "Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation" 278 : 25481-25489, 2003

      56 Itoh, Y., "Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40" 422 : 173-176, 2003

      57 Fauser, J. K., "Fatty acids as potential adjunctive colorectal chemotherapeutic agents" 11 : 724-731, 2011

      58 Karaki, S., "Expression of the short-chain fatty acid receptor, GPR43, in the human colon" 39 : 135-142, 2008

      59 Stempelj, M., "Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate" 282 : 9797-9804, 2007

      60 Arumugam, M., "Enterotypes of the human gut microbiome" 473 : 174-180, 2011

      61 Macfarlane, G. T, "Englyst, Starch utilization by the human large intestinal microflora" 60 : 195-201, 1986

      62 Bergman, E. N., "Energy contributions of volatile fatty acids from the gastrointestinal tract in various species" 70 : 567-590, 1990

      63 Cho, K. K., "Effects of various buffers on rumen pH, VFA, and blood PCV in sheep" 13 : 156-160, 1989

      64 Cho, K. K., "Effects of various buffer sources and their levels in the diet on milk production, blood measures and nutrient digestibilities of Holstein dairy cows" 13 : 161-167, 1989

      65 Nano, J. L., "Effects of fatty acids on the growth of Caco-2 cells" 69 : 207-215, 2003

      66 Gope, R., "Effect of sodium butyrate on the expression of retinoblastoma (RB1) and P53 gene and phosphorylation of retinoblastoma protein in human colon tumor cell line HT29" 39 : 589-597, 1993

      67 Narayanan, B. A., "Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells" 19 : 1255-1262, 2001

      68 Kato, T., "Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status" 58 : 178-187, 2007

      69 Toit-Kohn, J. L., "Docosahexaenoic Acid induces apoptosis in colorectal carcinoma cells by modulating the Pi3 kinase and P38 Mapk pathways" 20 : 106-114, 2009

      70 Eckburg, P. B., "Diversity of the human intestinal microbial flora" 308 : 1635-1638, 2005

      71 Church, D. C., "Digestive physiology and nutrition of ruminants" Oxford press 1979

      72 Engelbrecht, A. M., "Differential induction of apoptosis and inhibition of the Pi3-kinase pathway by saturated, monounsaturated and polyunsaturated fatty acids in a colon cancer cell model" 13 : 1368-1377, 2008

      73 Avivi-Green, C., "Different molecular events account for butyrate-induced apoptosis in two human colon cancer cell lines" 132 : 1812-1818, 2002

      74 Dashwood, R. H., "Dietary histone deacetylase inhibitors: from cells to mice to man" 17 : 363-369, 2007

      75 Jami, E., "Composition and similarity of bovine rumen microbiota across individual animals" 7 : 33306-, 2012

      76 Schonberg, S. A., "Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1" 273 : 2749-2765, 2006

      77 Key, T. J., "Cancer incidence in vegetarians: results from the european prospective Investigation into cancer and nutrition (EPIC-Oxford)" 89 : 1620-1626, 2009

      78 Levy, P., "Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation" 197 : 336-347, 2003

      79 Serpa, J., "Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells" 285 : 39211-39223, 2010

      80 Litvak, D. A., "Butyrate-induced differentiation of Caco-2 cells is associated with apoptosis and early induction of p21waf1/Cip1 and p27kip1" 124 : 161-170, 1998

      81 Domokos, M., "Butyrate-induced cell death and differentiation are associated with distinct patterns of ROS in HT29-derived human colon cancer cells" 55 : 920-930, 2010

      82 Fung, K. Y., "Butyrate-induced apoptosis in HCT116 colorectal cancer cells includes induction of a cell stress response" 10 : 1860-1869, 2011

      83 McIntyre, A., "Butyrate production from dietary fibre and protection against large bowel cancer in a rat model" 34 : 386-391, 1993

      84 Janson, W., "Butyrate modulates DNA-damage-induced p53 response by induction of p53-independent differentiation and apoptosis" 15 : 1395-1406, 1997

      85 Ruemmele, F. M., "Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP)" 6 : 729-735, 1999

      86 Ruemmele, F. M., "Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway" 52 : 194-100, 2003

      87 Buda, A., "Butyrate downregulates alpha2beta1 integrin: a possible role in the induction of apoptosis in colorectal cancer cell lines" 52 : 729-734, 2003

      88 Clarke, J. M., "Butyrate delivered by butyrylated starch increases distal colonic epithelial apoptosis in carcinogen-treated rats" 33 : 197-202, 2012

      89 Dethlefsen, L., "Assembly of the human intestinal microbiota" 21 : 517-523, 2006

      90 Cho, K. K., "Apoptosis, programmed cell death" 20 : 289-310, 1998

      91 Morrison, M., "Adhesion to cellulose by Ruminococcus albus: a combination of cellulosomes and Pil-proteins" 185 : 109-115, 2000

      92 Lopez de Silanes, I., "Acquisition of resistance to butyrate enhances survival after stress and induces malignancy of human colon carcinoma cells" 64 : 4593-4600, 2004

      93 Fung, K. Y., "A review of the potential mechanisms for the lowering of colorectal oncogenesis by butyrate" 5 : 820-831, 2012

      94 Flint, H. J., "A bifunctional enzyme, with separate xylanase and beta (1, 3-1, 4)-glucanase domains, encoded by the xynD gene of Ruminococcus flavefaciens" 175 : 2943-2951, 1993

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2027 평가예정 재인증평가 신청대상 (재인증)
      2021-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2018-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2015-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2011-08-03 학술지명변경 외국어명 : Korean Journal of Life Science -> Journal of Life Science KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2003-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2001-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.37 0.37 0.42
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.43 0.43 0.774 0.09
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼